Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1985 1
1987 1
1989 1
1992 1
1993 2
1994 1
1995 4
1999 2
2000 1
2001 1
2002 2
2003 3
2004 4
2005 2
2006 2
2007 4
2008 8
2009 7
2010 3
2011 7
2012 10
2013 11
2014 7
2015 8
2016 10
2017 6
2018 4
2019 1
2020 4
2021 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Rationale for individualizing haemophilia care.
Sørensen B, Auerswald G, Benson G, Elezović I, Felder M, Lambert T, Morfini M, Remor E, Salaj P, Santagostino E, Šalek SZ, Ljung R. Sørensen B, et al. Among authors: auerswald g. Blood Coagul Fibrinolysis. 2015 Dec;26(8):849-57. doi: 10.1097/MBC.0000000000000225. Blood Coagul Fibrinolysis. 2015. PMID: 25396764 Review.
Beyond patient benefit: clinical development in hemophilia.
Auerswald G, Šalek SZ, Benson G, Elezović I, Lambert T, Morfini M, Pasi J, Remor E, Santagostino E, Salaj P, Ljung R. Auerswald G, et al. Hematology. 2012 Jan;17(1):1-8. doi: 10.1179/102453312X13221316477372. Hematology. 2012. PMID: 22549441 Free article. Review.
Outcome measures for adult and pediatric hemophilia patients with inhibitors.
Hermans C, Auerswald G, Benson G, Dolan G, Duffy A, Jiménez-Yuste V, Ljung R, Morfini M, Lambert T, Osooli M, Zupančić Šalek S. Hermans C, et al. Among authors: auerswald g. Eur J Haematol. 2017 Aug;99(2):103-111. doi: 10.1111/ejh.12881. Epub 2017 Apr 25. Eur J Haematol. 2017. PMID: 28332238 Review.
When should prophylaxis therapy in inhibitor patients be considered?
Young G, Auerswald G, Jimenez-Yuste V, Konkle BA, Lambert T, Morfini M, Santagostino E, Blanchette V. Young G, et al. Among authors: auerswald g. Haemophilia. 2011 Sep;17(5):e849-57. doi: 10.1111/j.1365-2516.2011.02494.x. Epub 2011 Mar 21. Haemophilia. 2011. PMID: 21418444 Review.
The case for wider use of recombinant factor VIII concentrates.
Hermans C, Brackmann HH, Schinco P, Auerswald G. Hermans C, et al. Among authors: auerswald g. Crit Rev Oncol Hematol. 2012 Jul;83(1):11-20. doi: 10.1016/j.critrevonc.2011.08.001. Epub 2011 Oct 2. Crit Rev Oncol Hematol. 2012. PMID: 21964312 Review.
Switching treatments in haemophilia: is there a risk of inhibitor development?
Santagostino E, Auerswald G, Benson G, Dolan G, Jiménez-Yuste V, Lambert T, Ljung R, Morfini M, Remor E, Zupančić Šalek S. Santagostino E, et al. Among authors: auerswald g. Eur J Haematol. 2015 Apr;94(4):284-9. doi: 10.1111/ejh.12433. Epub 2014 Sep 17. Eur J Haematol. 2015. PMID: 25135593 Free PMC article. Review.
106 results